Related Experiment Video
Updated: Dec 1, 2025

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
Cardiovascular Manifestations and Mechanisms in Patients with COVID-19
Qingyu Dou1, Xin Wei2, Kehua Zhou3
1National Clinical Research Center of Geriatrics, Geriatric Medicine Center, West China Hospital, Sichuan University, Chengdu, China; International Institute of Spatial Lifecourse Epidemiology (ISLE), Hong Kong, China.
Insights
Patients with cardiovascular disease (CVD) face higher mortality from COVID-19. This review details COVID-19
Area of Science:
- Cardiology
- Infectious Diseases
- Pathology
Background:
- Patients with pre-existing cardiovascular disease (CVD) or developing cardiovascular complications during COVID-19 infection exhibit increased mortality risk.
- COVID-19 presents with diverse cardiovascular complications, including acute cardiac injury, myocardial infarction, myocarditis, arrhythmias, heart failure, shock, and thromboembolism (pulmonary embolism).
Purpose of the Study:
- To systematically review the cardiovascular manifestations, histopathology, and underlying mechanisms of COVID-19.
- To guide future research and therapeutic strategy development for managing COVID-19-associated cardiovascular complications.
Main Methods:
- Systematic literature review of cardiovascular aspects in COVID-19 patients.
- Analysis of reported cardiovascular complications, histopathological findings, and proposed pathomechanisms.
Main Results:
- COVID-19 can precipitate or exacerbate cardiovascular disease through direct viral effects or indirect mechanisms.
- Key mechanisms include viral toxicity, RAAS dysregulation, endothelial dysfunction, cytokine storm, and oxygen imbalance.
- Cardiovascular complications significantly contribute to the morbidity and mortality in COVID-19.
Conclusions:
- Understanding the intricate relationship between COVID-19 and cardiovascular disease is crucial for effective patient management.
- Further research into the pathobiology and therapeutic interventions for COVID-19 cardiovascular complications is warranted.
Abstract:
Coronavirus disease 2019 (COVID-19) patients with pre-existing cardiovascular disease (CVD) or with cardiovascular complications have a higher risk of mortality. The main cardiovascular complications of COVID-19 include acute cardiac injury, acute myocardial infarction (AMI), myocarditis, arrhythmia, heart failure, shock, and venous thromboembolism (VTE)/pulmonary embolism (PE). COVID-19 can cause cardiovascular complications or deterioration of coexisting CVD through direct or indirect mechanisms, including viral toxicity, dysregulation of the renin-angiotensin-aldosterone system (RAAS), endothelial cell damage and thromboinflammation, cytokine storm, and oxygen supply-demand mismatch. We systematically review cardiovascular manifestations, histopathology, and mechanisms of COVID-19, to help to formulate future research goals and facilitate the development of therapeutic management strategies.
Related Concept Videos
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Heart Failure III: Clinical Manifestations
Cardiomyopathy II: Dilated Cardiomyopathy
Endocarditis II: Clinical Features of Infective Endocarditis
Myocarditis II: Clinical Features and Diagnostic Tests

